NATIXIS - TRANSMEDICS GROUP INC ownership

TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 222 filers reported holding TRANSMEDICS GROUP INC in Q3 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.

Quarter-by-quarter ownership
NATIXIS ownership history of TRANSMEDICS GROUP INC
ValueSharesWeighting
Q3 2023$1,629,196
-43.7%
29,757
-13.7%
0.01%
-50.0%
Q2 2023$2,895,798
+10.3%
34,482
-0.6%
0.02%0.0%
Q1 2023$2,626,165
-40.4%
34,678
-51.4%
0.02%
-4.0%
Q4 2022$4,406,067
+171.5%
71,388
+93.0%
0.02%
+212.5%
Q3 2022$1,623,000
+88.7%
36,996
+30.6%
0.01%
+166.7%
Q2 2022$860,00028,3200.00%
Other shareholders
TRANSMEDICS GROUP INC shareholders Q3 2023
NameSharesValueWeighting ↓
KPCB XIII Associates, LLC 923,221$30,632,0005.64%
Sandhill Capital Partners LLC 1,429,432$47,429,0003.70%
Bullseye Asset Management LLC 117,471$3,898,0001.31%
Taylor Wealth Management Partners 72,685$2,412,0000.85%
Signature Wealth Management Partners, LLC 14,000$465,0000.42%
EMERALD MUTUAL FUND ADVISERS TRUST 369,259$12,252,0000.40%
Triumph Capital Management 20,051$622,0000.36%
EMERALD ADVISERS, LLC 300,464$9,969,0000.36%
ESSEX INVESTMENT MANAGEMENT CO LLC 76,347$2,533,0000.30%
Bellevue Group AG 729,989$24,221,0000.24%
View complete list of TRANSMEDICS GROUP INC shareholders